Beneficial effects of Renin-Angiotensin system blockers on testicular steroidogenesis

J Urol. 2014 Dec;192(6):1878-83. doi: 10.1016/j.juro.2014.05.093. Epub 2014 May 28.

Abstract

Purpose: We evaluated whether antihypertensive drugs that act through the renin-angiotensin system would affect testis function.

Materials and methods: Ten mice were fed standard chow and 40 received a high energy density diet. At 8 weeks the high energy density diet mice were divided into 4 groups of 10 each. The untreated group received the high energy density diet alone. The 3 treated groups received that diet plus aliskiren (50 mg/kg daily), enalapril (30 mg/kg daily) and losartan (10 mg/kg daily), respectively, for the next 6 weeks. Blood pressure was measured twice monthly. At the end of the treatment period all mice were sacrificed. One-way ANOVA and the Holm-Sidak post hoc test were used to analyze results.

Results: The high energy density diet led to a significant increase in blood pressure (p <0.05). All treatments resulted in normalized blood pressure. In regard to reproductive function, and serum testosterone and estradiol the gene and protein expression of StAR, aromatase and luteinizing hormone receptor, and the protein expression of angiotensin-converting enzyme, renin and angiotensin type 1 receptor blocker were significantly decreased by the high energy density diet. Of the treatments only enalapril reverted the changes. Also, angiotensin-converting enzyme, angiotensin type 1 receptor blocker and renin protein expression were lower in all high energy density diet groups except the group that received enalapril.

Conclusions: Only angiotensin-converting enzyme inhibitor reverted the hormonal and testis alterations caused by the high energy density diet. This suggests that enalapril should be the drug of choice for a patient who presents with previous reproductive dysfunction.

Keywords: diet; enalapril; hypercholesterolemia; hypertension; testis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin-Converting Enzyme Inhibitors / pharmacology*
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Animals
  • Enalapril / pharmacology*
  • Enalapril / therapeutic use
  • Hypertension / drug therapy
  • Hypertension / metabolism
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Phosphoproteins / biosynthesis*
  • Renin-Angiotensin System / drug effects*
  • Testis / drug effects*
  • Testis / metabolism*

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Phosphoproteins
  • steroidogenic acute regulatory protein
  • Enalapril